Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

Open access
Krishnaswamy, Soundararajan, Kanteti, Rajani, Duke-Cohan, Jonathan S., Loganathan, Sivakumar, Liu, Wanqing, Ma, Patrick C., Sattler, Martin, Singleton, Patrick A., Ramnath, Nithya, Innocenti, Federico, Nicolae, Dan L., Ouyang, Zheng, Liang, Jie, Minna, John, Kozloff, Mark F., Ferguson, Mark K., Natarajan, Viswanathan, Wang, Yi-Ching, Garcia, Joe G.N., Vokes, Everett E., Salgia, Ravi · 2009 · Clinical Cancer Research

Abstract

Purpose: African Americans have higher incidence and poorer response to lung cancer treatment compared with Caucasians. However, the underlying molecular mechanisms for the significant ethnic difference are not known. The present study examines the ethnic differences in the type and frequency of MET proto-oncogene (MET) mutation in lung cancer and correlated them with other frequently mutated genes such as epidermal growth factor receptor (EGFR), KRAS2, and TP53. Experimental Design: Using tumor tissue genomic DNA from 141 Asian, 76 Caucasian, and 66 African American lung cancer patients, exons coding for MET and EGFR were PCR amplified, and mutations were detected by sequencing. Mutation carriers were further screened for KRAS2 and TP53 mutations. Functional implications of important MET mutations were explored by molecular modeling and hepatocyte growth factor binding studies. Results: Unlike the frequently encountered somatic mutations in EGFR, MET mutations in lung tumors were germline. MET-N375S, the most frequent mutation of MET, occurred in 13% of East Asians compared with none in African Americans. The frequency of MET mutations was highest among male smokers and squamous cell carcinoma. The MET-N375S mutation seems to confer resistance to MET inhibition based on hepatocyte growth factor ligand binding, molecular modeling, and apoptotic susceptibility to MET inhibitor studies. Conclusions: MET in lung cancer tissues contained nonsynonymous mutations in the semaphorin and juxtamembrane domains but not in the tyrosine kinase domain. All the MET mutations were germline. East Asians, African-Americans, and Caucasians had different MET genotypes and haplotypes. MET mutations in the semaphorin domain affected ligand binding. (Clin Cancer Res 2009;15(18):5714–23)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-09-0070

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 184

Metadata

Authors
Krishnaswamy, S., Kanteti, R., Duke-Cohan, J. S., Loganathan, S., Liu, W., Ma, P. C., Sattler, M., Singleton, P. A., Ramnath, N., Innocenti, F., Nicolae, D. L., Ouyang, Z., Liang, J., Minna, J., Kozloff, M. F., Ferguson, M. K., Natarajan, V., Wang, Y.-C., Garcia, J. G. N., Vokes, E. E., & Salgia, R.
Venue
Clinical Cancer Research
Published
2009-09-14
Volume
15
Issue
18
Pages
5714-5723
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2158424267
Cited by
184
References
6
FWCI
8.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-09-0070
The paper
Krishnaswamy, S., Kanteti, R., Duke-Cohan, J. S., Loganathan, S., Liu, W., Ma, P. C., Sattler, M., Singleton, P. A., Ramnath, N., Innocenti, F., Nicolae, D. L., Ouyang, Z., Liang, J., Minna, J., Kozloff, M. F., Ferguson, M. K., Natarajan, V., Wang, Y.-C., Garcia, J. G. N., . . . Salgia, R. (2009). Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-09-0070

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.